CTIS2023-508192-36-00招募中1 期
Immunogenicity and safety of a meningococcal serogroup B vaccine in adult patients with asplenia - MenB_Asplenia
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- •asplenia due to splenectomy or functional asplenia (only patients), 18 to 60 years of age, if female: have a negative urine pregnancy test result at study entry and agree to employ adequate birth control measures for the duration of the study, providing written informed consent
排除标准
- •previous vaccination against meningococcal serogroup B, pregnant or lactating, febrile illness within last two weeks prior to enrolment, allergic reactions to vaccination in past, chemotherapy with Rituximab within last six months or during study period (only patients), more than 20mg prednisone per day within last four weeks prior or at the time of enrolment (only patients), any immunosuppressive condition or medication (only healthy controls)
研究者
相似试验
招募中
4 期
MENPI: Safety and immunogenicity following meningococcal and pneumococcal immunization among adult people living with HIV. A single center, non-blinded, randomized clinical trial2024-516961-35-01Hvidovre Hospital55
已完成
3 期
Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian FederatioCTRI/2014/12/005272Sanofi Pasteur SA300
进行中（未招募）
不适用
Studies on evaluation of immunogenicity of meningococcal vaccine in KoreaCertain infectious and parasitic diseasesKCT0002460Ewha Womans University Medical Center90
进行中（未招募）
4 期
Meningococcal vaccine for 56 years old or olderJPRN-jRCT1061190014Tanaka Takaaki20
已完成
不适用
Immunogenicity and safety of quadrivalent meningococcal polysaccharide-protein conjugate vaccine among Japanese people aged >=56 yearsmeningococcal diseaseJPRN-UMIN000022803Tokyo Medical University Hospital Travellers' Medical Center23